Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Methocinnamox (MCAM) produces long-lasting antagonism of the behavioral effects of µ opioid receptor agonists but not prolonged precipitated withdrawal in rats.

Gerak LR, Minervini V, Latham E, Ghodrati S, Lillis KV, Wooden J, Disney A, Husbands SM, France CP.

J Pharmacol Exp Ther. 2019 Aug 22. pii: jpet.119.260331. doi: 10.1124/jpet.119.260331. [Epub ahead of print]

2.

Structure and function of dual-source cholinergic modulation in early vision.

Krueger J, Disney AA.

J Comp Neurol. 2019 Feb 15;527(3):738-750. doi: 10.1002/cne.24590. Epub 2018 Dec 20. Review.

PMID:
30520037
3.

Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel μ-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys.

Gerak LR, Maguire DR, Woods JH, Husbands SM, Disney A, France CP.

J Pharmacol Exp Ther. 2019 Feb;368(2):229-236. doi: 10.1124/jpet.118.253286. Epub 2018 Nov 21.

PMID:
30463875
4.

Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys.

Maguire DR, Gerak LR, Woods JH, Husbands SM, Disney A, France CP.

J Pharmacol Exp Ther. 2019 Jan;368(1):88-99. doi: 10.1124/jpet.118.252353. Epub 2018 Nov 6.

PMID:
30401680
6.

The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception.

Hill R, Disney A, Conibear A, Sutcliffe K, Dewey W, Husbands S, Bailey C, Kelly E, Henderson G.

Br J Pharmacol. 2018 Jul;175(13):2653-2661. doi: 10.1111/bph.14224. Epub 2018 May 14.

7.

Is There a Canonical Cortical Circuit for the Cholinergic System? Anatomical Differences Across Common Model Systems.

Coppola JJ, Disney AA.

Front Neural Circuits. 2018 Jan 30;12:8. doi: 10.3389/fncir.2018.00008. eCollection 2018. Review.

8.

Modulatory compartments in cortex and local regulation of cholinergic tone.

Coppola JJ, Ward NJ, Jadi MP, Disney AA.

J Physiol Paris. 2016 Sep;110(1-2):3-9. doi: 10.1016/j.jphysparis.2016.08.001. Epub 2016 Aug 21.

9.

Optogenetic manipulation of neural circuits in awake marmosets.

MacDougall M, Nummela SU, Coop S, Disney A, Mitchell JF, Miller CT.

J Neurophysiol. 2016 Sep 1;116(3):1286-94. doi: 10.1152/jn.00197.2016. Epub 2016 Jun 22.

10.

Alkylation of Staurosporine to Derive a Kinase Probe for Fluorescence Applications.

Disney AJ, Kellam B, Dekker LV.

ChemMedChem. 2016 May 6;11(9):972-9. doi: 10.1002/cmdc.201500589. Epub 2016 Mar 23.

11.

A multi-site array for combined local electrochemistry and electrophysiology in the non-human primate brain.

Disney AA, McKinney C, Grissom L, Lu X, Reynolds JH.

J Neurosci Methods. 2015 Nov 30;255:29-37. doi: 10.1016/j.jneumeth.2015.07.009. Epub 2015 Jul 29.

12.

Muscarinic acetylcholine receptors are expressed by most parvalbumin-immunoreactive neurons in area MT of the macaque.

Disney AA, Alasady HA, Reynolds JH.

Brain Behav. 2014 May;4(3):431-45. doi: 10.1002/brb3.225. Epub 2014 Mar 21.

14.

NICE recommendations for the assessment of stable chest pain: assessing the early economic and service impact in the rapid-access chest pain service.

Ashrafi R, Raga S, Abdool A, Disney A, Wong P, Davis GK.

Postgrad Med J. 2013 May;89(1051):251-7. doi: 10.1136/postgradmedj-2012-131098. Epub 2013 Feb 12.

PMID:
23404743
15.

Orthogonal micro-organization of orientation and spatial frequency in primate primary visual cortex.

Nauhaus I, Nielsen KJ, Disney AA, Callaway EM.

Nat Neurosci. 2012 Dec;15(12):1683-90. doi: 10.1038/nn.3255. Epub 2012 Nov 11. Erratum in: Nat Neurosci. 2013 Dec;16(12):1907.

16.

Cholinergic suppression of visual responses in primate V1 is mediated by GABAergic inhibition.

Disney AA, Aoki C, Hawken MJ.

J Neurophysiol. 2012 Oct;108(7):1907-23. doi: 10.1152/jn.00188.2012. Epub 2012 Jul 11.

17.

Psychosocial variables are associated with being wait-listed, but not with receiving a kidney transplant in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Szeifert L, Bragg-Gresham JL, Thumma J, Gillespie BW, Mucsi I, Robinson BM, Pisoni RL, Disney A, Combe C, Port FK.

Nephrol Dial Transplant. 2012 May;27(5):2107-13. doi: 10.1093/ndt/gfr568. Epub 2011 Nov 5.

PMID:
22058174
18.

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy.

Wizemann V, Tong L, Satayathum S, Disney A, Akiba T, Fissell RB, Kerr PG, Young EW, Robinson BM.

Kidney Int. 2010 Jun;77(12):1098-106. doi: 10.1038/ki.2009.477. Epub 2010 Jan 6.

19.

Quantitative analysis of neurons with Kv3 potassium channel subunits, Kv3.1b and Kv3.2, in macaque primary visual cortex.

Constantinople CM, Disney AA, Maffie J, Rudy B, Hawken MJ.

J Comp Neurol. 2009 Oct 1;516(4):291-311. doi: 10.1002/cne.22111.

20.

The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Combe C, Albert JM, Bragg-Gresham JL, Andreucci VE, Disney A, Fukuhara S, Goodkin DA, Gillespie BW, Saito A, Jadoul M, Pisoni RL.

Am J Kidney Dis. 2009 Oct;54(4):680-92. doi: 10.1053/j.ajkd.2009.04.035. Epub 2009 Jul 19.

PMID:
19619923
21.

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease.

Roger SD, Suranyi MG, Walker RG, Disney A, Isbel NM, Kairaitis L, Pollock CA, Brown FG, Chow J, Truman MI, Ulyate KA; COMFORT study group.

Curr Med Res Opin. 2008 Aug;24(8):2181-7. doi: 10.1185/03007990802240552. Epub 2008 Jun 18.

PMID:
18565240
22.

Successful treatment of pulmonary mucormycosis in a renal transplant recipient with limited pulmonary reserve by combined medical and surgical therapy.

Li JY, Yong TY, Jurisevic CA, Russ GR, Grove DI, Coates PT, Disney AP.

Heart Lung Circ. 2009 Jun;18(3):226-8. doi: 10.1016/j.hlc.2007.12.003. Epub 2008 Mar 4.

PMID:
18296117
23.

Muscarinic acetylcholine receptors in macaque V1 are most frequently expressed by parvalbumin-immunoreactive neurons.

Disney AA, Aoki C.

J Comp Neurol. 2008 Apr 10;507(5):1748-62. doi: 10.1002/cne.21616.

24.

Bilateral basal ganglia lesions in patients with end-stage diabetic nephropathy.

Li JY, Yong TY, Sebben R, Khoo E, Disney AP.

Nephrology (Carlton). 2008 Feb;13(1):68-72. doi: 10.1111/j.1440-1797.2007.00838.x.

PMID:
18199107
25.

Gain modulation by nicotine in macaque v1.

Disney AA, Aoki C, Hawken MJ.

Neuron. 2007 Nov 21;56(4):701-13.

26.

Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism.

Sterrett JR, Strom J, Stummvoll HK, Bahner U, Disney A, Soroka SD, Corpier C, Arruda JA, Schwanauer LE, Klassen PS, Olson KA, Block GA.

Clin Nephrol. 2007 Jul;68(1):10-7.

PMID:
17703830
27.

Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical data.

Carrera F, Disney A, Molina M.

Nephrol Dial Transplant. 2007 Jun;22 Suppl 4:iv19-iv30. Review.

PMID:
17526546
28.

Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian study.

Disney A, Jersey PD, Kirkland G, Mantha M, Charlesworth JA, Gallagher M, Harris D, Gock H, Mangos GJ, Macmillan J, Liu W, Viswalingam A.

Nephrology (Carlton). 2007 Feb;12(1):95-101.

PMID:
17295668
30.

The CARI guidelines. Dialysis adequacy (HD) guidelines.

Kerr P, Perkovic V, Petrie J, Agar J, Disney A; Caring for Australians with Renal Impairment (CARI).

Nephrology (Carlton). 2005 Oct;10 Suppl 4:S61-80. No abstract available.

PMID:
16221128
31.

Randomized cross-over comparison of intravenous and subcutaneous darbepoetin dosing efficiency in haemodialysis patients.

Cervelli MJ, Gray N, McDonald S, Gentgall MG, Disney AP.

Nephrology (Carlton). 2005 Apr;10(2):129-35.

PMID:
15877671
32.
33.

Recommendations for the use of icodextrin in peritoneal dialysis patients.

Johnson DW, Agar J, Collins J, Disney A, Harris DC, Ibels L, Irish A, Saltissi D, Suranyi M.

Nephrology (Carlton). 2003 Feb;8(1):1-7. Review.

PMID:
15012742
34.

Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial.

Roger SD, McMahon LP, Clarkson A, Disney A, Harris D, Hawley C, Healy H, Kerr P, Lynn K, Parnham A, Pascoe R, Voss D, Walker R, Levin A.

J Am Soc Nephrol. 2004 Jan;15(1):148-56.

35.

Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.

Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P.

J Am Soc Nephrol. 2003 Jan;14(1):197-207.

36.

Neurosteroids mediate habituation and tonic inhibition in the auditory midbrain.

Disney A, Calford MB.

J Neurophysiol. 2001 Aug;86(2):1052-6.

37.

An unusual case of port site seeding.

Neuhaus S, Hewett P, Disney A.

Surg Endosc. 2001 Aug;15(8):896. Epub 2001 May 7.

PMID:
11443429
38.

Predialysis immunosuppression is an independent risk factor for some cancers in renal transplantation.

Hibberd AD, Trevillian PR, Wlodarzcyk JH, Gillies AH, Stein AM, Sheil AG, Disney AP.

Transplant Proc. 2001 Feb-Mar;33(1-2):1846-7. No abstract available.

PMID:
11267538
39.

Recurrence of cancer after renal transplantation.

Chapman JR, Sheil AG, Disney AP.

Transplant Proc. 2001 Feb-Mar;33(1-2):1830-1. No abstract available.

PMID:
11267531
40.

Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.

MacGinley R, Westhuyzen J, Saltissi D, Morgan C, Healy H, Thirlwell GK, Disney AP.

ASAIO J. 2001 Jan-Feb;47(1):66-73.

PMID:
11199319
41.

Evaluation of hand function in patients undergoing long term haemodialysis.

Limaye V, Frankham A, Disney A, Pile K.

Ann Rheum Dis. 2001 Mar;60(3):278-80.

42.

Shoulder appearances at MR imaging in long-term dialysis recipients.

Slavotinek JP, Coates PT, McDonald SP, Disney AP, Sage MR.

Radiology. 2000 Nov;217(2):539-43.

PMID:
11058657
43.

Treatment of peritoneal dialysis related peritonitis--an Australian and New Zealand perspective.

Murphy BF, Harris DC, Disney A, Ibels LS, Saltissi D, Rigby R, Suranyi M, Collins J.

Aust N Z J Med. 1999 Aug;29(4):552-5. No abstract available.

PMID:
10868534
44.

Renal telemedicine to the home.

Mitchell JG, Disney AP, Roberts M.

J Telemed Telecare. 2000;6(1):59-62. No abstract available.

PMID:
10824394
45.

Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study.

Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P.

Am J Kidney Dis. 2000 Jan;35(1):157-65.

PMID:
10620560
46.

The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients.

Chew CG, Weise MD, Disney AP.

Nephrol Dial Transplant. 1999 Aug;14(8):2047-9. No abstract available.

PMID:
10462304
47.

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P.

Lancet. 1999 Jul 10;354(9173):93-9.

PMID:
10408483
48.

Cancer risk associated with ATG/OKT3 in renal transplantation.

Hibberd AD, Trevillian PR, Wlodarzcyk JH, Gillies AH, Stein AM, Sheil AG, Disney AP.

Transplant Proc. 1999 Feb-Mar;31(1-2):1271-2. No abstract available.

PMID:
10083567
49.

Cutaneous necrosis from calcific uremic arteriolopathy.

Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney AP.

Am J Kidney Dis. 1998 Sep;32(3):384-91. Review.

PMID:
9740153
50.

Amyloid, advanced glycation end products, and dialysis related arthropathy.

McDonald SP, Coates PT, Disney AP.

Ann Rheum Dis. 1998 Apr;57(4):193-5. No abstract available.

Supplemental Content

Loading ...
Support Center